Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ligo Biosciences
AddedJun 25, 2026
UpdatedJul 2, 2026
Ligo Biosciences

Ligo Biosciences

Seed

Enzyme design models.

HQ
San Francisco, CA, US
Accelerator
Y Combinator logoY CombinatorS24
Overview
Compare
Fundraising
Employees
Website

The $6 trillion chemical industry is flawed: It produces 20% of industrial greenhouse gases, and is responsible for 15% of global energy usage.

Enzymes offer a far more sustainable alternative to chemical synthesis and have already revolutionised how a select few chemicals are produced. is each enzyme takes years of trial and error to develop.

Ligo Biosciences - Similar Companies

Anthrogen logo

Anthrogen

anthrogen.com

ReactWise logo

ReactWise

reactwise.com

Synthetic Sciences logo

Synthetic Sciences

AbInitio Bio logo

AbInitio Bio

abinitio-bio.com

b12 Labs logo

b12 Labs

b12-labs.com

The Synthesis Company logo

The Synthesis Company

Convexia logo

Convexia

convexia.bio

ACX logo

ACX

Partcl logo

Partcl

partcl.com

Anto Biosciences logo

Anto Biosciences

anto.bio

BioStack Platforms logo

BioStack Platforms

getbiostack.com

Ångström AI logo

Ångström AI

angstrom-ai.com

CellType logo

CellType

celltype.com

Synthio Labs logo

Synthio Labs

synthiolabs.com

The Token Company logo

The Token Company

Ligo Biosciences - Quick Facts

Who are Ligo Biosciences' competitors?

Companies similar to Ligo Biosciences include Anthrogen, ReactWise, Synthetic Sciences and AbInitio Bio.

Where is Ligo Biosciences' headquarters located?

Ligo Biosciences' headquarters is located in San Francisco, CA, US.

When was Ligo Biosciences' last funding round?

Ligo Biosciences' most recent funding round was for $500k (USD) in June 2024.

How much has Ligo Biosciences raised to-date?

As of Jun 1, 2024, Ligo Biosciences has raised a total of $500k (USD).